Home » Clinical Trials » Location » Japan
Search Medical Condition
One Or Multiple Investigational Sites, Japan Clinical Trials
A listing of One Or Multiple Investigational Sites, Japan clinical trials actively recruiting patients volunteers.
Found (58033) clinical trials
Early Alzheimers Disease
Enrolling men and women who have signs of early stage Alzheimer's Disease. The clinical trial is evaluating whether an investigational combined treatment slows down, arrests, or reverses early stage Alzheimer's disease.
A Washington University research study seeks overweight participants.
The purpose of this study is to compare cardiometabolic health between metabolically-normal and metabolically abnormal obese participants. This study will last up to 1 year. Participants will visit the research center about 8 times before randomization. The outpatient visits range from less than 1 hour to approximately 6 hours in ...
A Phase 3 Study (PHOCUS) to determine whether the oncolytic virus immunotherapy called Pexa-Vec (JX-594) can slow the progression of advanced liver cancer (hepatocellular carcinoma or HCC).
This research study is for people with advanced liver cancer who have never received systemic medicine (affecting the entire body) for advanced liver cancer. This is a randomized, open-label Phase 3 study to determine whether treatment with vaccinia virus based immunotherapy (Pexa-Vec) followed by sorafenib can slow the progression of ...
Moderate to Severe Ulcerative Colitis
The True North Study is a clinical research study assessing an investigational medication (a potential new medication that is under development) for the treatment of people with ulcerative colitis.
Early Alzheimer’s disease
A global research study needs people aged 50 to 85 concerned by their memory changes. If you or someone you know is experiencing memory loss or has early Alzheimer’s disease, you may qualify and receive at no cost: Investigational drug Study-related care from a local study doctor Reimbursement for travel ...
A Phase 2 Multiple Dose, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease.
This study seeks to evaluate the efficacy and safety of ABBV-8E12 in subjects with Early Alzheimer's Disease.
To evaluate the efficacy of multiple dose levels of NYX-2925 versus placebo in treating the neuropathic pain associated with Diabetic Peripheral Neuropathy.
This study will see if an investigational drug called NYX-2925 can reduce the nerve pain in the legs and feet associated with painful diabetic peripheral neuropathy.
Phase 3 Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Evaluation Of The Efficacy, Safety, And Tolerability Of A Study Compound, In Reducing The Occurrence Of Major Cardiovascular Events In High Risk Subjects
A clinical research trial to prevent cardiovascular events due to high lipid or cholesterol levels
A Placebo-Controlled, Double-Blind, Parallel-Group, 24 Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
The name of this trial is MissionAD1. This 24-month treatment, multicenter, double-blind, placebo-controlled, parallel group, Phase 3 study in participants with Early Alzheimer's Disease (EAD) including mild cognitive impairment (MCI) due to AD/Prodromal AD and the early stages of mild AD will be conducted to evaluate the efficacy and safety ...
